Development of a yeast-based immunoassay for SARS-CoV-2 serologic testing amenable to inexpensive local production

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:4 publications

Grant number: 172773

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Known Financial Commitments (USD)

    $134,355
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    David Ross Mcmillen
  • Research Location

    Canada
  • Lead Research Institution

    University of Toronto Mississauga (ON) Chemical and Physical Sciences
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

To monitor the spread of the COVID-19 pandemic and test individuals for potential immunity, we need antibody detection tests, where a blood sample is checked for the presence of antibodies induced by past exposure to the virus. These tests are often expensive, requiring either a fully-equipped laboratory with highly trained technical staff, or costing many dollars per test for field-deployable "strip tests". Sending tests to a lab or paying a few dollars per test does not perhaps seem like a problem, here in Canada, but in our partner nation of the Philippines, both of these present significant barriers: public health dollars are sharply limited, and remote areas have very limited access to lab facilities and technical staff. Our goal is to create an antibody detection test that can be "grown" locally, here in Canada and in the Philippines. By modifying baker's yeast (S. cerevisiae), we can put antibody-binding proteins (antigens) on their surfaces, able to capture disease-induced antibodies found in blood samples. We test for the presence of these antibodies with an agglutination test: when the yeast cells settle to the bottom of a round well, in the absence of antibodies they form into a tight button that looks like a dot to the naked eye; or in the presence of antibodies they form larger clumps that stay more spread out and look like a flat sheet to the naked eye. A minimally-trained user can thus obtain a positive or negative result with no expensive instruments. The yeast (once designed) can be grown in a simple sugar solution, at a raw material cost that we estimate to be something less than 0.01 cents per test. We have demonstrated lab-bench success at detecting Chagas' disease and dengue fever antibodies, and now we propose to adapt the technique to detect COVID-19 antibodies and develop it in a fully deployable kit for use in under-resourced areas. Our first target is the Philippines, with the help of our collaborators at UP Manila.

Publicationslinked via Europe PMC

Prosocial behavior in students with intellectual disabilities: Individual level predictors and the role of the classroom peer context.

Challenging behaviour in students with intellectual disabilities: the role of individual and classmates' communication skills.

Gender Differences in Peer Influence on Autistic Traits in Special Needs Schools-Evidence From Staff Reports.